 Psychotic Disorders
"Psychotic Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Descriptor ID |
D011618
|
| MeSH Number(s) |
F03.700.675
|
| Concept/Terms |
Psychotic Disorders- Psychotic Disorders
- Disorder, Psychotic
- Disorders, Psychotic
- Psychotic Disorder
- Psychosis
- Psychoses
Schizoaffective Disorder- Schizoaffective Disorder
- Disorder, Schizoaffective
- Disorders, Schizoaffective
- Schizoaffective Disorders
Schizophreniform Disorders- Schizophreniform Disorders
- Disorder, Schizophreniform
- Disorders, Schizophreniform
- Schizophreniform Disorder
Psychosis, Brief Reactive- Psychosis, Brief Reactive
- Brief Reactive Psychoses
- Brief Reactive Psychosis
- Psychoses, Brief Reactive
- Reactive Psychoses, Brief
- Reactive Psychosis, Brief
|
Below are MeSH descriptors whose meaning is more general than "Psychotic Disorders".
Below are MeSH descriptors whose meaning is more specific than "Psychotic Disorders".
This graph shows the total number of publications written about "Psychotic Disorders" by people in UAMS Profiles by year, and whether "Psychotic Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2021 | 5 | 1 | 6 | | 2020 | 0 | 1 | 1 | | 2019 | 3 | 1 | 4 | | 2018 | 5 | 1 | 6 | | 2017 | 2 | 0 | 2 | | 2016 | 3 | 0 | 3 | | 2015 | 3 | 2 | 5 | | 2014 | 4 | 1 | 5 | | 2013 | 7 | 1 | 8 | | 2012 | 5 | 0 | 5 | | 2011 | 4 | 1 | 5 | | 2010 | 1 | 0 | 1 | | 2009 | 2 | 1 | 3 | | 2008 | 2 | 0 | 2 | | 2007 | 3 | 3 | 6 | | 2006 | 3 | 2 | 5 | | 2005 | 3 | 0 | 3 | | 2004 | 2 | 0 | 2 | | 2003 | 5 | 0 | 5 | | 2002 | 4 | 2 | 6 | | 2001 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 1999 | 2 | 1 | 3 | | 1997 | 3 | 0 | 3 | | 1996 | 2 | 0 | 2 | | 1995 | 1 | 2 | 3 | | 1994 | 1 | 1 | 2 | | 1993 | 1 | 0 | 1 | | 1992 | 0 | 2 | 2 | | 1991 | 3 | 1 | 4 | | 1990 | 1 | 1 | 2 | | 1989 | 2 | 0 | 2 | | 1988 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Psychotic Disorders" by people in Profiles over the past ten years.
-
Hwang M, Roh YS, Talero J, Cohen BM, Baker JT, Brady RO, Öngür D, Shinn AK. Auditory hallucinations across the psychosis spectrum: Evidence of dysconnectivity involving cerebellar and temporal lobe regions. Neuroimage Clin. 2021; 32:102893.
-
Cohen BM, Öngür D, Babb SM. Alternative Diagnostic Models of the Psychotic Disorders: Evidence-Based Choices. Psychother Psychosom. 2021; 90(6):373-385.
-
Bider EN, Coker JL. Postpartum psychosis and SARS-CoV-2 infection: is there a correlation? Arch Womens Ment Health. 2021 12; 24(6):1051-1054.
-
Ferrara M, Guloksuz S, Mathis WS, Li F, Lin IH, Syed S, Gallagher K, Shah J, Kline E, Tek C, Keshavan M, Srihari VH. First help-seeking attempt before and after psychosis onset: measures of delay and aversive pathways to care. Soc Psychiatry Psychiatr Epidemiol. 2021 Aug; 56(8):1359-1369.
-
Gallagher K, Ferrara M, Pollard J, Yoviene Sykes L, Li F, Imetovski S, Cahill J, Mathis W, Srihari VH. Taking the next step: Improving care transitions from a first-episode psychosis service. Early Interv Psychiatry. 2022 01; 16(1):91-96.
-
Kopel J, Grooms A, Ganapathy V, Clothier J. Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity. Psychiatr Genet. 2021 02 01; 31(1):32-35.
-
Desai R, Patel K, Dave H, Shah K, DeWitt N, Fong HK, Varma Y, Varma K, Mansuri Z, Sachdeva R, Khanna A, Kumar G. Nationwide Frequency, Sequential Trends, and Impact of Co-morbid Mental Health Disorders on Hospitalizations, Outcomes, and Healthcare Resource Utilization in Adult Congenital Heart Disease. Am J Cardiol. 2020 04 15; 125(8):1256-1262.
-
Hanna B, Desai R, Parekh T, Guirguis E, Kumar G, Sachdeva R. Psychiatric disorders in the U.S. transgender population. Ann Epidemiol. 2019 11; 39:1-7.e1.
-
Hull LE, Chanfreau-Coffinier C, Tuteja S, Berlowitz D, Lehmann LS, Oslin DW, Pyne JM, DuVall SL, Lynch JA. Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications. Pharmacogenomics. 2019 07; 20(11):781-789.
-
Chouinard VA, Shinn AK, Valeri L, Chouinard PA, Gardner ME, Asan AE, Cohen BM, Öngür D. Visual hallucinations associated with multimodal hallucinations, suicide attempts and morbidity of illness in psychotic disorders. Schizophr Res. 2019 06; 208:196-201.
-
Wilson MP, Shenvi C, Rives L, Nordstrom K, Schneider S, Gerardi M. Opportunities for Research in Mental Health Emergencies: Executive Summary and Methodology. West J Emerg Med. 2019 Mar; 20(2):380-385.
-
Martinez-Martin N, Dunn LB, Roberts LW. Is It Ethical to Use Prognostic Estimates from Machine Learning to Treat Psychosis? AMA J Ethics. 2018 09 01; 20(9):E804-811.
-
Mathis WS, Woods S, Srihari V. Blind Spots: Spatial analytics can identify nonrandom geographic variation in first episode psychosis program enrollments. Early Interv Psychiatry. 2018 12; 12(6):1229-1234.
-
Zhou TH, Mueller NE, Spencer KM, Mallya SG, Lewandowski KE, Norris LA, Levy DL, Cohen BM, Öngür D, Hall MH. Auditory steady state response deficits are associated with symptom severity and poor functioning in patients with psychotic disorder. Schizophr Res. 2018 11; 201:278-286.
-
Chouinard VA, Henderson DC, Dalla Man C, Valeri L, Gray BE, Ryan KP, Cypess AM, Cobelli C, Cohen BM, Öngür D. Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis. Mol Psychiatry. 2019 10; 24(10):1513-1522.
-
Yuksel C, Yilmaz S, Nesbit A, Carkaxhiu G, Ravichandran C, Salvatore P, Pingali S, Cohen B, Ongur D. Demographic and clinical characteristics associated with a history of bizarre delusions in a cross-diagnostic sample of individuals with psychotic disorders. Asian J Psychiatr. 2018 Jan; 31:82-85.
-
Spears CA, Jones DM, Weaver SR, Pechacek TF, Eriksen MP. Motives and perceptions regarding electronic nicotine delivery systems (ENDS) use among adults with mental health conditions. Addict Behav. 2018 05; 80:102-109.
-
Ravichandran C, Shinn AK, Öngür D, Perlis RH, Cohen B. Frequency of non-right-handedness in bipolar disorder and schizophrenia. Psychiatry Res. 2017 07; 253:267-269.
-
Chouinard VA, Kim SY, Valeri L, Yuksel C, Ryan KP, Chouinard G, Cohen BM, Du F, Öngür D. Brain bioenergetics and redox state measured by 31P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders. Schizophr Res. 2017 09; 187:11-16.
-
Corbett B, Nordstrom K, Vilke GM, Wilson MP. Psychiatric Emergencies for Clinicians: Emergency Department Diagnosis and Management of Steroid Psychosis. J Emerg Med. 2016 Nov; 51(5):557-560.
-
Lewandowski KE, Sperry SH, Ongur D, Cohen BM, Norris LA, Keshavan MS. Cognitive remediation versus active computer control in bipolar disorder with psychosis: study protocol for a randomized controlled trial. Trials. 2016 Mar 12; 17(1):136.
-
Chouinard VA, Pingali SM, Chouinard G, Henderson DC, Mallya SG, Cypess AM, Cohen BM, Öngür D. Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders. Psychiatry Res. 2016 Mar 30; 237:304-10.
-
Moran LV, Masters GA, Pingali S, Cohen BM, Liebson E, Rajarethinam RP, Ongur D. Prescription stimulant use is associated with earlier onset of psychosis. J Psychiatr Res. 2015 Dec; 71:41-7.
-
Golden LE, Sassoon P, Cáceda R. A case report of late onset psychosis with dementia and aspirin and caffeine addiction. Schizophr Res. 2015 Oct; 168(1-2):591-2.
-
Wong D, Tortorelli S, Bishop L, Sellars EA, Schimmenti LA, Gallant N, Prada CE, Hopkin RJ, Leslie ND, Berry SA, Rosenblatt DS, Fair AL, Matern D, Raymond K, Oglesbee D, Rinaldo P, Gavrilov D. Outcomes of four patients with homocysteine remethylation disorders detected by newborn screening. Genet Med. 2016 Feb; 18(2):162-7.
-
Lewandowski KE, Ongür D, Sperry SH, Cohen BM, Sehovic S, Goldbach JR, Du F. Myelin vs axon abnormalities in white matter in bipolar disorder. Neuropsychopharmacology. 2015 Mar 13; 40(5):1243-9.
-
Martin EA, Öngür D, Cohen BM, Lewandowski KE. Social functioning and age across affective and nonaffective psychoses. J Nerv Ment Dis. 2015 Jan; 203(1):37-42.
-
Dholaria BR, Pant S, Lavender RC, Agarwal A. The great imitator: psychosis that responded to penicillin. Can Fam Physician. 2014 Sep; 60(9):818-21.
-
Mittal D, Li C, Viverito K, Williams JS, Landes RD, Thapa PB, Owen R. Monitoring for metabolic side effects among outpatients with dementia receiving antipsychotics. Psychiatr Serv. 2014 Sep 01; 65(9):1147-53.
-
Holmes KJ, Gathright MM, Morris EM, Coffey B. Psychotic symptoms and catatonia in a preadolescent boy with autism spectrum disorder. J Child Adolesc Psychopharmacol. 2014 Jun; 24(5):288-92.
-
Lewandowski KE, Sperry SH, Cohen BM, Ongür D. Cognitive variability in psychotic disorders: a cross-diagnostic cluster analysis. Psychol Med. 2014 Nov; 44(15):3239-48.
-
Sherer M, Yablon SA, Nick TG. Psychotic symptoms as manifestations of the posttraumatic confusional state: prevalence, risk factors, and association with outcome. J Head Trauma Rehabil. 2014 Mar-Apr; 29(2):E11-8.
-
Chandler A, Freeze-Ramsey R, Seupaul RA. Is the use of haloperidol a safe and effective method of tranquilization for patients with psychosis-induced aggression or agitation? Ann Emerg Med. 2014 Jun; 63(6):757-8.
-
Hall MH, Levy DL, Salisbury DF, Haddad S, Gallagher P, Lohan M, Cohen B, Ongür D, Smoller JW. Neurophysiologic effect of GWAS derived schizophrenia and bipolar risk variants. Am J Med Genet B Neuropsychiatr Genet. 2014 Jan; 165B(1):9-18.
-
Cummings J, Isaacson S, Mills R, Williams H, Chi-Burris K, Corbett A, Dhall R, Ballard C. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet. 2014 Feb 08; 383(9916):533-40.
-
Owen RR, Drummond KL, Viverito KM, Marchant K, Pope SK, Smith JL, Landes RD. Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation. Implement Sci. 2013 Oct 08; 8:120.
-
Lewandowski KE, Cohen BM, Keshavan MS, Sperry SH, Ongür D. Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up. Schizophr Res. 2013 Aug; 148(1-3):34-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|